J Biomol Struct Dyn

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies.

Giron CC, Laaksonen A, Barroso da Silva FL

J Biomol Struct Dyn - (-) 1-21 [2022-07-09; online 2022-07-09]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article

Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19.

Velu P, Rathinavel T, Kumarasamy S, ..., Rajamanickam K, Shanmugam G

J Biomol Struct Dyn - (-) 1-17 [2022-02-09; online 2022-02-09]

Category: Genomics & transcriptomics Category: Health Category: Public Health Type: Journal article